Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 6, 2009 - Issue 9
Submit an article Journal homepage
481
Views
36
CrossRef citations to date
0
Altmetric
Reviews

Assessment methods of inhaled aerosols: technical aspects and applications

Chiraz Jaafar-Maalej Université Claude Bernard Lyon 1, Laboratoire d'Automatique et de Génie des Procédés (LAGEP), bât 308G ESCPE-Lyon, 2ème étage, 43 bd du 11 Novembre 1918, 69622 Villeurbanne Cedex, France +0033 4 72 43 18 93; +0033 4 72 43 16 82; [email protected]
, PhD,
Véronique Andrieu Faculté de Pharmacie, Département de Pharmacie Galénique, 13385 Marseille, France
,
Abdelhamid Elaissari Université Claude Bernard Lyon 1, Laboratoire d'Automatique et de Génie des Procédés (LAGEP), bât 308G ESCPE-Lyon, 2ème étage, 43 bd du 11 Novembre 1918, 69622 Villeurbanne Cedex, France +0033 4 72 43 18 93; +0033 4 72 43 16 82; [email protected]
&
Hatem Fessi Université Claude Bernard Lyon 1, Laboratoire d'Automatique et de Génie des Procédés (LAGEP), bât 308G ESCPE-Lyon, 2ème étage, 43 bd du 11 Novembre 1918, 69622 Villeurbanne Cedex, France +0033 4 72 43 18 93; +0033 4 72 43 16 82; [email protected]
Pages 941-959 | Published online: 29 Jul 2009

Bibliography

  • Frijlink H, De-Boer H. Dry powder inhalers for pulmonary drug delivery. Expert Opin Drug Deliv 2004;1(1):67-86
  • Newhouse M, Corkery K. Aerosols for systemic delivery of macromolecules. Respir Care Clin N Am 2001;7(2):261-75
  • Karathanasis E, Ayyagaric A, Bhavane R, et al. Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. J Control Release 2005;103(1-2):159-75
  • Trammer B, Amann A, Haltner-Ukomadu E. Comparative permeability and diffusion kinetics of cyclosporine: a liposomes and propylene glycol solution from human lung tissue into human blood ex vivo. Eur J Pharm Biopharm 2008;70(3):758-64
  • Stark B, Andreae F, Mosgoeller W. Liposomal vasoactive intestinal peptide for lung application: protection from proteolytic degradation. Eur J Pharm Biopharm 2008;70(1):153-64
  • Elversson J, Millqvist-Fureby A, Alderborn G, et al. Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray-drying. J Pharm Sci 2003;92(4):900-10
  • Bosquillon C, Rouxhet P, Ahimou F. Aerosolization properties, surface composition and physical state of spray-dried protein powders. J Control Release 2004;99(3):357-67
  • Sbirlea-Apiou G, Katz I, Caillibotte G, et al. Inhalation aerosols: physical and biological basis for therapy. Hickey AJ: Informa healthcare, 2006
  • Kusmartseva O, Kattige A, Price R, et al. In-line assessment of pulmonary drug delivery using light obscuration. Biosens Bioelectron 2004;20(3):468-74
  • Levitzky M. Pulmonary Physiology. McGraw-Hill Medical Publishing Division, New York, USA. 2003
  • Gunasekara L, Schürch S, Schoel W. Pulmonary surfactant function is abolished by an elevated proportion of cholesterol. Biochim Biophys Acta: Mol Cell Biol Lipids 2005;1737(1):27-35
  • Forbes B. Human airway epithelial cell lines for in vitro drug transport and metabolism studies. Pharm Sci Technol Today 2000;3(1):18-27
  • Chang M, Shih L, Wu R. The Pulmonary Epithelium in Health and Disease. David Proud: Wiley, UK. 2008
  • Florea B, Cassara M, Junginger H, et al. Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J Control Release 2003;87(1-3):131-8
  • Finlay W. Pharmaceutical inhalation aerosol technology. Hickey AJ: Marcel Dekker, New York, USA. 2003
  • Wright J. Pulmonary surfactant: a front line of lung host defense. J Clin Invest 2003;111(10):1453-5
  • Phillips J, Hey J, Corboz M. Computer assisted measurement of airway gland secretions by the hillocks technique. Comput Methods Programs Biomed 2002;68(3):215-22
  • Rubin B. Physiology of airway mucus clearance. Respir Care 2002;47(7):761-8
  • King M. Physiology of mucus clearance. Paediatr Respir Rev 2006;7(1):S212-4
  • Samet J, Cheng P. The role of airway mucus in pulmonary toxicology. Environ Health Perspect 1994;102(2):89-103
  • Edsbäckera S, Wollmerb P, Selroosc O, et al. Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?. Pulm Pharmacol Ther 2008;21(2):247-58
  • Wang L, Scabilloni J, Antonini J. Role of lung surfactant in phagocytic clearance of apoptotic cells by macrophages in rats. Lab Invest 2006;86(5):458-66
  • Jain D, Dodia C, Fisher A, et al. Pathways for clearance of surfactant protein A from the lung. Am J Physiol Lung Cell Mol Physiol 2005;289(6):L1011-8
  • Wang J, Reid K. The immunoregulatory roles of lung surfactant collectins SP-A, and SP-D, in allergen-induced airway inflammation. Immunobiology 2007;212(4):417-25
  • Leonenko Z, Finot E, Vassiliev V, et al. Effect of cholesterol on the physical properties of pulmonary surfactant films:atomic force measurements study. Ultramicroscopy 2006;106(8):687-94
  • McCrae K, Rand T, Shaw R. Analysis of pulmonary surfactant by Fourier-transform infrared spectroscopy following exposure to Stachybotrys chartarum (atra) spores. Chem Phys Lipids 2001;110(1):1-10
  • Foot N, Orgeig S, Daniels C. The evolution of a physiological system: the pulmonary surfactant system in diving mammals. Respir Physiol Neurobiol 2006;154(1):118-38
  • Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2001;2(1):33-46
  • Biddiscombe M, Usmani O, Barnes P. A system for the production and delivery of monodisperse salbutamol aerosols to the lungs. Int J Pharm 2003;254(2):243-53
  • Scheuch G, Siekmeier R. Novel approaches to enhance pulmonary delivery of proteins and peptides. J Physiol Pharmacol 2007;58(5):615-25
  • Scheuch G, Kohlhaeufl M, Brand P, et al. Clinical perspectives on pulmonary systemic and macromolecular delivery. Adv Drug Deliv Rev 2006;58(9-10):996-1008
  • Groneberg D, Paul H, Welte T. Novel strategies of aerosolic pharmacotherapy. Exp Toxicol Pathol 2006;57(2):49-53
  • Heyder J. Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc 2004;1(4):315-20
  • Khilnani G, Banga A. Aerosol therapy. Indian J Chest Dis Allied Sci 2008;50(2):209-19
  • Groneberge DA, Witt C, Wagner U, et al. Fundamentals of pulmonary drug delivery. Respir Med 2003;97(44):382-7
  • Labiris N, Dolovich M. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 2003;56(6):588-99
  • Ma Z, Merkus H, Scarlett B. Extending laser diffraction for particle shape characterization: technical aspects and application. Powder Technol 2001;118(1-2):180-7
  • Ma Z, Merkus H, De Smet J. New developments in particle characterization by laser diffraction: size and shape. Powder Technol 2000;111(1):66-78
  • Mitchell J, Nagel M, Nichols S, et al. Laser diffractometry as a technique for the rapid assessment of aerosol particle size from inhalers. J Aerosol Med 2006;19(4):409-33
  • Haynes A, Shaik A, Krarup H, et al. Evaluation of the malvern spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers. J Pharm Sci 2004;93(2):349-63
  • Waldrep JC, Berlinski A, Dhand R. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer. J Aerosol Med 2007;20(3):310-9
  • De-Boer A, Gjaltema D, Hagedoorn P, et al. Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols. Int J Pharm 2002;249(1-2):233-45
  • Mitchell J, Nagel M. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. J Aerosol Med 2003;16(4):341-77
  • Sethuraman V, Hickey A. Evaluation of preseparator performance for the 8-stage nonviable andersen impactor. AAPS PharmSciTech 2001;2(1):1-19
  • Kim M, Kim D, Lee K. Multijet and multistage aerosol concentrator: design and performance analysis. J Aerosol Med 2001;14(2):245-54
  • EP 6.0. Preparations for inhalation: aerodynamic assessment of fine particles. Europeen Pharamacopeia 6.0, 2008
  • USP 26-NF21. Physical tests and determinations: aerosols. United states Pharmacopeia: Rockville MD, 2003
  • Marple VA, Rubow KL. Generation of Aerosols and Facilities for Exposure Experiments, Chapter 1: Aerosol Generation Concepts and Parameters, Ed K. Willeke, Ann Arbor Science Publishers, Inc. Ann Arbor, MI, 1980
  • Hering S, Flagan R, Friedlander S. Design and evaluation of a new low-pressure impactor. Environ Sci Technol 1978;12(6):667-73
  • Newman S, Wilding I, Hirst P. Human lung deposition data: the bridge between in vitro and clinical evaluations for inhaled drug products?. Int J Pharm 2000;208(1-2):49-60
  • Newman S, Pitcairn G. In vitro/in vivo correlations for respiratory drug delivery. Clin Res Regul Aff 2005;22(1):15-30
  • Marple V, Roberts D, Romay F. Next generation pharmaceutical impactor (A new impactor for pharmaceutical inhaler testing) /Part 1. Design. J Aerosol Med 2003;16(3):283-99
  • Hoe S, Young P, Chan H, et al. Introduction of the electrical next generation impactor (eNGI) and investigation of its capabilities for the study of pressurized metered dose inhalers. Pharm Res 2009;26(2):431-7
  • Bonam M, Christopher D, Cipolla D, et al. Minimizing variability of cascade impaction measurements in inhalers and nebulizers. AAPS PharmSciTech 2008;9(2):404-13
  • Stapleton K, Finlay W. Errors in characterizing particle size distributions with cascade impactors. J Aerosol Med 1998;11(1):S80-3
  • Zhou Y, Ahuja A, Irvin C. Medical nebulizer performance: effects of cascade impactor temperature. Respir Care 2005;50(8):1077-82
  • Nerbrink OL, Pagels J, Pieron CA, et al. Effect of humidity on constant output and breath enhanced nebulizer designs when tested in the EN13544-1 EC Standard. Aerosol Sci Technol 2003;37(3):282-92
  • Zhou Y, Ahuja A, Irvin C. Evaluation of nebulizer performance under various humidity conditions. J Aerosol Med 2005;18(3):283-93
  • Solomita M, Smaldone G. Reconciliation of cascade impaction during wet nebulization. J Aerosol Med Pulm Drug Deliv 2009;22(1):1-8
  • Nasr M, Ross D, Miller N. Effect of drug load and plate coating on the particle size distribution of a commercial albuterol Metered Dose Inhaler (MDI) determined using the Andersen and Marple-Miller cascade impactors. Pharm Res 1997;14(10):1437-43
  • Mitchell J, Nagel M. Particle size analysis of aerosols from medicinal inhalers. KONA: Powder Particle 2004;22:32-65
  • Bosquillon C, Lombry C, Preat V, et al. Comparison of particle sizing techniques in the case of inhalation dry powders. J Pharm Sci 2001;90(12):2032-41
  • Schroeter J, Fleming J, Hwang D, et al. A computer model of lung morphology to analyze SPECT images. Comput Med Imaging Graph 2002;26(4):237-46
  • Dolovich M, Labiris R. Imaging drug delivery and drug responses in the lung. Proc Am Thorac Soc 2004;1(4):329-37
  • Chan H. Encyclopedia of pharmaceutical technology. James Swarbrick: Marcel Dekker, New York, USA. 2002
  • Newman S, Pitcairn G, Hirst P, et al. Radionuclide imaging technologies and their use in evaluating asthma drug deposition in the lungs. Adv Drug Deliv Rev 2003;55(7):851-67
  • Fleming J, Conway J. Three-dimensional imaging of aerosol deposition. J Aerosol Med 2001;14(2):147-53
  • Snell N, Ganderton D. Assessing lung deposition of inhaled medications–Consensus statement from a workshop of the British Association for Lung Research. Respir Med 1999;93(2):123-33
  • Dolovich M. Pharmaceutical inhalation aerosol technology. Hickey AJ: Marcel Dekker, New York, USA. 2004
  • Tafaghodi M, Sajadi-Tabassi S, Jaafari M. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. Int J Pharm 2004;280(1-2):125-35
  • Möller W, Meyer G, Kreyling W. Advances in lung imaging techniques for the treatment of respiratory disease. Drug Discov Today: Ther Strateg 2008;5(2):87-92
  • Lee Z, Berridge M, Finlay W, et al. Mapping PET-measured triamcinolone acetonide (TAA) aerosol distribution into deposition by airway generation. Int J Pharm 2000;199(1):7-16
  • Mobley C, Hochhaus G. Methods used to assess pulmonary deposition and absorption of drugs. Drug Discov Today 2001;6(7):367-75
  • Newman S. Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs? Br J Clin Pharmacol 2000;49(6):529-37
  • Newman S, Hirst P, Wilding I. New developments in radionuclide imaging for assessing drug delivery in man. Eur J Pharm Sci 2003;18(1):19-22
  • Davies G, Nuermberger E. Pharmacokinetics and pharmacodynamics in the development of anti-tuberculosis drugs. Tuberculosis 2008;88(1):S65-74
  • Lipworth B. Pharmacokinectics of inhaled drugs. Br J Clin Pharmacol 1996;42(6):697-705
  • Girodet P, Molimard M. Pharmacological approach to evaluate aerosol pulmonary deposition. J Aerosol Med 2005;18(2):183-92
  • Derendorf H, Nave R, Drollmann A. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J 2006;28(5):1042-50
  • Chrystyn H. Methods to determine lung distribution of inhaled drugs–could gamma scintigraphy be the gold standard?. Br J Clin Pharmacol 2000;49(6):525-8
  • Esposito-Festen J, Zanen P, Tiddens H, et al. Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size. Br J Clin Pharmacol 2007;64(3):328-34
  • Derendorf H, Hochhaus G, Möllmann H. Evaluation of pulmonary absorption using pharmacokinetic methods. J Aerosol Med 2000;14(1):9-17
  • Hirst P, Pitcairn G, Richards J. Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide delivered by pressurized metered dose inhaler. J Aerosol Med 2001;14(2):155-65
  • Cass LM, Brown J, Pickford M, et al. Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers. Clin Pharmacokinet 1999;36(1):21-31
  • Sebti T, Pilcer G, Van Gansbeke B, et al. Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation. Eur J Pharm Biopharm 2006;64(1):26-32
  • Mitsakou C, Helmis C, Housiadas C. Eulerian modelling of lung deposition with sectional representation of aerosol dynamics. J Aerosol Sci 2005;36(1):75-94
  • Asgharian B, Hofmann W, Bergmann R. Particle deposition in a multiple-path model of the human lung. Aerosol Sci Technol 2001;34(4):332-9
  • Goo J, Kim C. Theoretical analysis of particle deposition in human lungs considering stochastic variations of airway morphology. J Aerosol Sci 2003;34(5):585-602
  • International Commission on Radiological Protection Human respiratory tract model for radiological protection. A report of a task group of the International Commission on Radiological Protection. Ann ICRP 1994;24:1-120
  • Moskal A, Gradon L. Temporary and spatial deposition of aerosol particles in the upper human airways during breathing cycle. J Aerosol Sci 2002;33(11):1525-39
  • Sturm R, Hofmann W. Stochastic simulation of alveolar particle deposition in lungs affected by different types of emphysema. J Aerosol Med 2004;17(4):357-72
  • Balásházy I, Alföldy B, Molnár A. Aerosol drug delivery optimization by computational methods for the characterization of total and regional deposition of therapeutic aerosols in the respiratory system. Curr Comput Aided Drug Des 2007;3(1):13-32
  • Dunbar C, Scheuc G, Sommerer K. In vitro and in vivo dose delivery characteristics of large porous particles for inhalation. Int J Pharm 2002;245(1-2):179-89
  • Fleming J, Epps B, Conway J, et al. Comparison of SPECT aerosol deposition data with a human respiratory tract model. J Aerosol Med 2006;19(3):268-78
  • Zhang Y, Finlay W. Experimental measurements of particle deposition in three proximal lung bifurcation models with an idealized mouth-Throat. J Aerosol Med 2005;18(4):460-73
  • Kamiya A, Sakagami M, Hindle M, et al. Aerodynamic sizing of metered dose inhalers: an evaluation of the andersen and next generation pharmaceutical impactors and their USP methods. J Pharm Sci 2004;93(7):1828-37
  • Guo C, Gillespie S, Kauffman J, et al. Comparison of delivery characteristics from a combination metered-dose inhaler using the andersen cascade impactor and the next generation pharmaceutical impactor. J Pharm Sci 2008;97(8):3321-34
  • Garmise R, Hickey A. Calibration of the andersen cascade impactor for the characterization of nasal products. J Pharm Sci 2008;97(8):3462-6
  • Pilcer G, Vanderbist F, Amighi K. Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations. Int J Pharm 2008;358(1-2):75-81
  • Marriott C, Macritchie H, Zeng X, et al. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations. Int J Pharm 2006;326(1-2):39-49
  • Ziegler J, Wachtel H. Comparison of cascade impaction and laser diffraction for particle size distribution measurements. J Aerosol Med 2005;18(3):311-24
  • Vecellio-None L, Grimbert D, Becquemin MH, et al. Validation of laser diffraction method as a substitute for cascade impaction in the European project for a nebulizer standard. J Aerosol Med 2001;14(1):107-14
  • Kwong W, Ho S, Coates A. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus andersen cascade impactor and low-flow Marple personal cascade impactor. J Aerosol Med 2000;13(4):303-14
  • Agertoft L, Pedersen S. Lung deposition and systemic availability of fluticasone diskus and budesonide turbuhaler in children. Am J Respir Crit Care Med 2003;168(7):779-82
  • Tomlinson H, Corlett S, Chrystyn H. Dose–response relationship and reproducibility of urinary salbutamol excretion during the first 30 min after an inhalation. Br J Clin Pharmacol 2003;56(2):225-7
  • Aswani O, Chrystyn H. Relative lung and systemic bioavailability of sodium cromoglycate inhaled products using urinary drug excretion post inhalation. Biopharm Drug Dispos 2002;23(4):159-63
  • Anderson P, Zhou X, Breen P. Pharmacokinetics of (R, S)-Albuterol after aerosol inhalation in healthy adult volunteers. J Pharm Sci 2000;87(7):841-4
  • Longest P, Xi J. Effectiveness of direct Lagrangian tracking models for simulating nanoparticle deposition in the upper airways. Aerosol Sci Technol 2007;41(4):380-97
  • Longest P, Vinchurkar S, Martonen T. Transport and deposition of respiratory aerosols in models of childhood asthma. J Aerosol Sci 2006;37(10):1234-57

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.